Single amino acid change drives coronavirus spillover from animals to humans

The question that haunts epidemiologists is deceptively simple: why do some animal viruses jump to humans and trigger catastrophe, while others remain confined to their original hosts? The answer, according to researchers working across four institutions, may hinge on something almost impossibly small—a single swap in the genetic code, one amino acid substituted for another in a viral protein called OrfB9.

The SARS-CoV-2 virus that sparked the COVID-19 pandemic did not emerge from nowhere. It shares ancestry with coronaviruses that have circulated harmlessly in bat populations for centuries. The virus that causes COVID-19 is, in essence, a bat virus that learned to thrive in human bodies. Understanding how that learning happened—what genetic adjustments allowed the leap—is the work of scientists at UCSF's Quantitative Biosciences Institute, Mount Sinai's Icahn School of Medicine, Institut Pasteur, and Fred Hutchinson Cancer Center. Their findings, published in Cell Host & Microbe in May, suggest that the difference between a benign animal pathogen and a human pandemic killer can be measured in single letters of the genetic alphabet.

The researchers compared SARS-CoV-2 with RaTG13, a coronavirus that infects only bats and causes them no apparent harm. They examined how each virus's proteins interacted with immune defenses in both bat and human lung cells. To conduct these experiments, they relied on laboratory-grown cells from the greater horseshoe bat—a cell line that had never before been available for this kind of work. What emerged from their testing was striking: the OrfB9 protein, present in both viruses, differed by exactly one amino acid out of roughly one hundred. That single substitution changed everything about how the virus behaved inside a human body.

In human lung cells, the SARS-CoV-2 version of OrfB9 silenced an immune alarm system—the cellular equivalent of cutting the wires on a burglar alarm. With that defense disabled, the virus multiplied freely. In bat lung cells, by contrast, the RaTG13 version of the same protein activated an immune protein that worked to suppress viral replication. The virus remained contained. The same protein, nearly identical in structure, had evolved to exploit the specific vulnerabilities of each species' immune system.

This finding reframes how scientists think about pandemic risk. The leap from animal to human is not a matter of chance or proximity alone. It is a matter of molecular fit—whether a virus's proteins can successfully manipulate the particular immune defenses that a new host species has evolved. A single genetic change, accumulated perhaps over years of circulation in animal populations, can suddenly make that fit possible. Nevan Krogan, director of the Quantitative Biosciences Institute and senior author of the study, described it as reading a molecular signature that predicts spillover risk. If researchers can identify these signatures before a virus makes the jump, they might construct an early warning system—a way to spot dangerous variants before they become pandemics.

The implications stretch beyond academic interest. Thousands of animal viruses circulate in wildlife populations right now. Most will never infect humans. But some will. The question is which ones, and when. By mapping how viral proteins interact with immune systems across species, scientists can begin to predict which animal viruses pose the greatest spillover risk. It is not a guarantee against future pandemics. But it is the kind of molecular-level understanding that might allow the world to see danger coming and act before the first human case appears.